Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.
FDA finalizes rule on using master files in biologics applications
The FDA on Friday issued a final rule explaining how sponsors can use master files — submissions to the agency with details on their manufacturing
February 10, 2024